Adma Biologics (ADMA) Revenue Growth (3y) (2015 - 2025)
Adma Biologics (ADMA) Revenue Growth (3y) (2015 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Revenue Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
0.73% |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
122.97% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
7.94% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Adma Biologics |
1.98 Bn |
1.89 Bn |
88.82 Mn |
40.68% |
| Date | Value |
|---|
| Dec 31, 2025 |
40.68% |
| Sep 30, 2025 |
48.38% |
| Jun 30, 2025 |
17.60% |
| Mar 31, 2025 |
58.00% |
| Dec 31, 2024 |
28.81% |
| Sep 30, 2024 |
79.62% |
| Jun 30, 2024 |
81.83% |
| Mar 31, 2024 |
72.15% |
| Dec 31, 2023 |
74.30% |
| Sep 30, 2023 |
120.39% |
| Jun 30, 2023 |
97.64% |
| Mar 31, 2023 |
77.37% |
| Dec 31, 2022 |
60.73% |
| Sep 30, 2022 |
78.52% |
| Jun 30, 2022 |
120.46% |
| Mar 31, 2022 |
102.04% |
| Dec 31, 2021 |
138.46% |
| Sep 30, 2021 |
69.72% |
| Jun 30, 2021 |
56.45% |
| Mar 31, 2021 |
58.35% |
